GPR39 as a Therapeutic Target in Vascular Cognitive Impairment and Dementia

The Sean Logan Distinguished Lecture Series on Neurodegeneration
Pittsburgh Institute for Neurodegenerative Diseases (PIND)

GPR39 as a Therapeutic Target in Vascular Cognitive Impairment and Dementia

Nabil J. Alkayed, MD, PhD
James Metcalfe Chair of Cardiovascular Medicine, Professor and Director of Research
Oregon Health & Science University
December 1, 2021 - 12:00pm
Zoom